INE540L01014
INE540L01014
ALKEM LABORATORIES LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 631.18B EUR | 665.94B EUR | 633.57B EUR | 658.44B EUR |
Enterprise Value | 616.33B EUR | 665.94B EUR | 651.57B EUR | 658.44B EUR |
Valuation Multiples | ||||
Trailing P/E | 29.26x | 30.87x | 27.53x | 31.88x |
Forward P/E | 23.59x | -- | -- | -- |
Price to Sales | 4.19x | 4.42x | 4.31x | 5.93x |
Price to Book | 4.57x | -- | 4.58x | -- |
EV/Revenue | 4.09x | 4.42x | 4.43x | 5.93x |
EV/EBITDA | 21.06x | 18.34x | 18.16x | 22.93x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |